(Alliance News) - Sareum Holdings PLC on Monday reported a narrower loss as the company prioritised completion of development work on its lead drug candidate. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Sareum Holdings PLC on Friday said it has ended a study of its drug SDC-1801 after safety issues observed in animals involved in the study. Read More
(Alliance News) - Sareum Holdings PLC on Tuesday reported a strategic collaboration with AI-driven drug discovery firm, Receptor.AI, as it looks to accelerate the identification of high-potential candidates for neuroinflammatory conditions. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Sareum Holdings PLC on Tuesday said a biopharma company in the US has served notice to terminate a development & commercialisation licence for Sareum's SRA737 clinical-stage cancer treatment. Read More
(Alliance News) - Stock prices in London opened mixed on Tuesday, kicking off an abbreviated trading day in a subdued fashion as the year winds down. Read More